期刊文献+

奥曲肽联合5-FU对体外培养的大肠癌细胞增殖及突变型p53蛋白表达的影响 被引量:2

The effects of combination of Octreotide and 5-FU on the proliferation and expression of mutant p53 protein in human colorectal cancer cells in vitro
下载PDF
导出
摘要 目的:通过生长抑素类似物奥曲肽(OCT)联合5-FU对体外培养的大肠癌细胞作用及对p53蛋白的影响为大肠癌的临床治疗提供一定的理论依据。方法:采用结肠癌细胞原代培养,采用MTT比色分析法测定奥曲肽与5-FU联合是否抑制作用增强;流式细胞仪间接免疫荧光技术检测药物作用后的肿瘤细胞突变型p53蛋白表达情况。结果:5-FU和奥曲肽联合应用对大肠癌的抑制率高于单独应用。5-FU和1.0μg/mlOCT组均抑制突变型p53蛋白的表达,联合用药组更为明显。结论:奥曲肽和5-FU都能抑制肿瘤细胞的突变型p53蛋白的表达,且联合应用抑制作用强于两者的单独应用,这可能是奥曲肽能增强5-FU对结肠癌细胞抑制作用的机制之一。 Objective To provide a few certain proofs for clinieal therapy with the effects of combination of Octreotide (OCT) and 5 - FU on the proliferation and expression of mutant p53 protein in human colorectal cancer cells in vitro. Method The efficaey of OCT combined with 5 - FU against the cancer cells was observed by MTT assay. Indirect immune fluorescent labeling and flow cytometry was employed to investigate the exprossion of mutation p53 protein. Results Combination of OCT and 5 - FU enhanced the action, and the inhibition ratio was higher than 5 - FU or OCT alone. Row eytometric analysis demonstrated a decreased FI, the expression of mutant p53 protein was decreased. Conclusion Both OCT and 5 - FU can inhibite the expression of mutant p53 protein in the cancer ceils, and the inhibition efficacy is higher than 5 - FU or OCT alone in vitro,so this may be one of the mechanisms that OCT can enhance the inhibition ratio of 5 - FU on colorectal cancer cells.
作者 李洪祥
出处 《吉林医学》 CAS 2008年第3期199-201,共3页 Jilin Medical Journal
关键词 奥曲肽 5-FU 人结直肠癌细胞 增殖 突变型P53 Octreotide 5 -FU Human colorectal cancer cells Proliferation Mutant p53 protein
  • 相关文献

参考文献13

  • 1韩忠宝,李洪祥,杨翊研.生长抑素联合阿霉素体外抑制结肠癌细胞的实验研究[J].吉林医学,2006,27(9):1012-1013. 被引量:2
  • 2Douziech N, Calvo E, Coulombe Z, et al. Inhibitory and stimulatory effects of somatostatin two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP - 1 [ J ]. Endocrinology, 1999, 140 (2) :765.
  • 3Raderer M, Hejna MH, Muller C, et al. Treatment of hepatocellular cancer with the longacting somatostatin analog lanreotide in vitro and in vlvo[ J]. INTJ Onxol, 2000, 16(6) : 1197.
  • 4Sharma K, Sricant CB. Induction of wild-type p53, Bax and acidic cndonucleasc during somatostat in 2 signaled apoptosis in MCF27 human breast cancer cells[J ]. Int J Cancer, 1998, 76 (2) :259.
  • 5刘明学,吴凯南.生长抑素及其类似物对肿瘤血管生成的影响[J].中华普通外科杂志,2002,17(12):763-765. 被引量:3
  • 6Baker SJ, Markowitz S, Fearon ER, et al. Suppression of human colorectal carcinoma cell growth by wild - type p.53 [ J ]. Science, 1990, 249:912.
  • 7Lane DP. p53,guardian of the genome[J]. Nature, 1992, 358 : 15.
  • 8茆家定,吴佩,夏祥厚,胡济群,黄文斌,徐国祥.生长抑素与大肠癌细胞凋亡及调控基因bcl-2、bax及p53关系的研究[J].皖南医学院学报,2003,22(4):250-252. 被引量:3
  • 9Bosari S, Viale G, Bossi P, et al. Cytolasmic accumulation of p53 protein: an independent prognostic indicator of colorectal adenocarcinimas[J]. Cancer Inst, 1994, 84:681.
  • 10Johnson KR, Young KK, Fan W. Antagonistic interplay between antirnitotic and G1 - S arresting agents observed in experimental combination therapy[J]. Clin Cancer Res, 1999, 5: 2559.

二级参考文献34

  • 1Fromowitz FB, Viola MV, Chao S, et al. Ras p21 expression in the progression of breast cancer [J ]. Human Pathol, 1987, 18:12681275.
  • 2Heinke MY, Yao M, Chang D, et al. Apoptosis of ventricular and atrial myocytes from pacing-induced canine heart failure[J ]. Cardiovasc Res ,2001 , 49:127-- 134.
  • 3Kang B,Jeong K,Park S,et al. Regulation of apoptosis of by somatostation and substance P in peritoneal macrophage[J]. Regul Rept,2001 , 101 (1-3) .'43--49.
  • 4Sharma K, Srikant CB. Induction of wild-type p53, bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells[J]. Cancer, 1998,76(2) :259.
  • 5Yan Y, Gong Z, Lon K, et al. Effects and mechanisms of somatostatin analogs on apoptosis of pancreatic acinar cells in acute pancreatitis in mice[J]. Gastroenterol Hepatol,2001 , 16(6) : 683--688.
  • 6Soffer SZ,Moore JT,Kim E,et al.Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor.J Pediatr Surg,2001,36:1177-1181.
  • 7Pollak MN,Schally AV.Mechanisms of antineoplastic action of somatostatin analogs.Proc Soc Exp Biol Med,1998,217:143-152.
  • 8Bauer W, Briner U, Doepfner W, et al.A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci, 1982, 31:1133-1140.
  • 9Plonowski A,Schally AV,Nagy A,et al.Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238.Cancer Res,2000,60:2996-3001.
  • 10Cuntz MC,Levine EA,O′Dorisio TM,et al.Intraoperative gamma detection of 125I-lanreotide in women with primary breast cancer.Ann Surg Oncol,1999,6:367-372.

共引文献5

同被引文献16

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部